Filing Details
- Accession Number:
- 0001437749-25-024250
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-31 20:38:50
- Reporting Period:
- 2025-07-29
- Filing Date:
- 2025-07-31
- Accepted Time:
- 2025-07-31 20:38:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 72444 | Vaxart Inc. | VXRT | Biological Products, (No Disgnostic Substances) (2836) | 591212264 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1612372 | Mark W. Watson | C/O Vaxart, Inc. 170 Harbor Way, Suite 300 South San Francisco CA 94080 | Yes | No | No | No |
Transaction Summary
| Purchased: | 10,000 shares | Avg. Price: $0.41 | Total Value: $4,050.00 |
| Number of Shares After Transactions: | 104,125 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-07-29 | 10,000 | $0.41 | 104,125 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
